The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

The FDA’s approval was based on a study of 11,400 people ages 12 and older that compared the new low-dose vaccine with ...

Kennedy Jr. has repeatedly questioned the safety of the mRNA technology Moderna planned to use ... Powell, the Federal Reserve chairman, met with Mr. Trump after months of attacks from the ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

In a crucial development, the FDA has approved Moderna's new COVID-19 vaccine designed specifically for high-risk Americans.